Navigation Links
Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
Date:1/6/2009

SAN DIEGO, Jan. 6 /PRNewswire/ -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate Accounts.

"Andrew brings the right mix of energy and expertise to Accumetrics. His experience will help us reach the next level in terms of our market penetration," says Timothy I. Still, President and CEO at Accumetrics. "His knowledge of the medical diagnostics industry and his relationships with distributors make him a key component of our growth strategy in 2009 and beyond."

Prior to joining Accumetrics, Mr. Chisholm served as Vice President of Sales and Corporate Accounts at Hemosense, a medical diagnostics company located in San Jose, California which was acquired by Inverness Medical in November 2007. Prior to that, Mr. Chisholm managed sales and marketing activities with increasing responsibilities at Bayer Healthcare, Henry Schein, Johnson & Johnson and the Eastman Kodak Company.

About Accumetrics (www.accumetrics.com):

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:  Jules Abraham
              Lippert Heilshorn & Associates
              212-838-3777
              jabraham@lhai.com

              Timothy I. Still
              Accumetrics
              press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Algeta Appoints Andrew Kay as President and Chief Executive Officer
2. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
3. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
4. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
5. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. Timothy I. Still Appointed CEO at Accumetrics
8. Robert Cantu Appointed Vice President of Pierpoint International
9. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
10. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
11. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... DuPont Pioneer and recently formed CasZyme, a ... a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal of ... across all applications. , Under the terms of the agreement, Pioneer will provide ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a ... biotechnology industries to improve patient outcomes and quality of life, will now be ... are being attributed to new regulatory requirements for all new drug products, including ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
Breaking Biology Technology:
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):